CH EPL (R5)
1.0.0 - trial-use Switzerland flag

This page is part of the CH EPL (R5) (v1.0.0: DSTU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

Example RegulatedAuthorization: 66231001

identifier: Marketing Authorisation Number/66231001

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-7601001001138-6623101-001; containedItemQuantity = 1 Vial; description = KEYTRUDA Inf Konz 100 mg/4ml Durchstf

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 2022-02-17

holder: Organization MSD Merck Sharp & Dohme AG

regulator: Organization SMC

Generated Narrative: Organization #holder-MSD-Merck-Sharp-Dohme-AG

identifier: LOC Identifier/100080484, GLN Identifier/7601001001138

name: MSD Merck Sharp & Dohme AG

Generated Narrative: Organization #regulator-SMC

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: SMC